Caris Life Sciences, Inc.

Caris Life Sciences analyzes tumor samples and blood tests to identify which cancer treatments are most likely to work for individual patients. The company uses genetic sequencing and artificial intelligence to examine cancer cells and look for early signs of cancer returning after treatment. They also provide research services to pharmaceutical companies developing new cancer drugs. Hospitals, cancer centers, and patients use their tests to make more targeted treatment decisions.